Jolywood N-Type TOPCon Recieved S&T Achievement Appraisal

ShanghaiMarch 27,2021Rcently,a S&T Achievement & New Product Appraisal Meeting on “High-efficiency N-type TOPCon Bifacial Solar Cells” of Jolywood (Taizhou) Solar Technology Co., Ltd. (SZSE: 300393), organized by Jiangsu Productivity Promotion Association and Industry and Information Technology Department of Jiangsu, was successfully convened in Taizhou.


At the meeting, Jolywood technical team reported recent major breakthroughs in the key technology of new-generation N-type TOPCon bifacial solar cell to the experts of the appraisal committee, which is composed of nearly 10 experts from universities and institutes. Later, the experts examined and appraised the S&T achievement and new product submitted by Jolywood.

After thorough discussion and inquiry, the experts agreed that Jolywood Solar’s High-efficiency N-type TOPCon Bifacial Solar Cells Technology  further improves its conversion efficiency with simplified processing sequence, which represents a major contribution to the promotion and application of novel efficient cell technology in the industry. The product and its main technical parameters reach the international leading level.

“The appraisal meeting provides a good opportunity for Jolywood to further develop the N-TOPCon technology. We quite appreciate the comments shared committee experts, and we will strengthen the transformation of S&T achievement to commercial product production, and boost the level of technological innovation and industrial development,” said Mr. Lin Jianwei, Chairman of Jolywood Group.

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.
©Copyright 2009-2020 Yahoo Perspective   cryydr@163.com   Contact Us   SiteMap